Construction and Validation of a Newly Prognostic Signature for CRISPR-Cas9-Based Cancer Dependency Map Genes in Breast Cancer

Figure 3

Validation of the six CDM gene-based signature in the TCGA training set. (a) The Kaplan–Meier curve for the overall survival (OS) of breast cancer samples based on the constructed signature in the TCGA training set. (b) Time-dependent receiver operating characteristic (ROC) curve analysis of the signature for predicting OS of patients with breast cancer. (c) Heatmap of the signature in the TCGA training set. (d) Risk score distribution and OS status in the TCGA training set.

(a)

(b)

(c)

(d)